Filter News
Area of Research
News Type
News Topics
- (-) Advanced Reactors (2)
- (-) Cybersecurity (2)
- (-) Isotopes (2)
- (-) Space Exploration (1)
- 3-D Printing/Advanced Manufacturing (1)
- Artificial Intelligence (7)
- Big Data (2)
- Bioenergy (2)
- Biomedical (3)
- Computer Science (22)
- Environment (1)
- Exascale Computing (2)
- Frontier (2)
- Grid (1)
- Materials Science (2)
- Molten Salt (1)
- Nanotechnology (1)
- Neutron Science (1)
- Nuclear Energy (7)
- Physics (2)
- Quantum Science (5)
- Security (1)
- Summit (9)
- Sustainable Energy (2)
- Transportation (1)
Media Contacts
Researchers at the Department of Energy’s Oak Ridge National Laboratory have received five 2019 R&D 100 Awards, increasing the lab’s total to 221 since the award’s inception in 1963.
The type of vehicle that will carry people to the Red Planet is shaping up to be “like a two-story house you’re trying to land on another planet.
Ask Tyler Gerczak to find a negative in working at the Department of Energy’s Oak Ridge National Laboratory, and his only complaint is the summer weather. It is not as forgiving as the summers in Pulaski, Wisconsin, his hometown.
OAK RIDGE, Tenn., Feb. 12, 2019—A team of researchers from the Department of Energy’s Oak Ridge and Los Alamos National Laboratories has partnered with EPB, a Chattanooga utility and telecommunications company, to demonstrate the effectiveness of metro-scale quantum key distribution (QKD).
The Department of Energy’s Oak Ridge National Laboratory is collaborating with industry on six new projects focused on advancing commercial nuclear energy technologies that offer potential improvements to current nuclear reactors and move new reactor designs closer to deployment.
A tiny vial of gray powder produced at the Department of Energy’s Oak Ridge National Laboratory is the backbone of a new experiment to study the intense magnetic fields created in nuclear collisions.
The Department of Energy’s Oak Ridge National Laboratory is now producing actinium-227 (Ac-227) to meet projected demand for a highly effective cancer drug through a 10-year contract between the U.S. DOE Isotope Program and Bayer.